SPRO
Spero Therapeutics, Inc. - Common Stock (SPRO)
$20
About Spero Therapeutics, Inc. - Common Stock (SPRO)
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.
Details
Daily high
$1.22
Daily low
$1.18
Price at open
$1.20
52 Week High
$3.08
52 Week Low
$1.08
Market cap
71.0M
Dividend yield
-
Volume
250,750
Avg. volume
463,811
P/E ratio
11.17
Spero Therapeutics, Inc. - Common Stock News
Details
Daily high
$1.22
Daily low
$1.18
Price at open
$1.20
52 Week High
$3.08
52 Week Low
$1.08
Market cap
71.0M
Dividend yield
-
Volume
250,750
Avg. volume
463,811
P/E ratio
11.17